|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
6
|
Resverlogix Corp.
|
Aug 05, 2017 01:46PM
|
|
Re: Money
|
6
|
Resverlogix Corp.
|
Jan 17, 2020 10:51AM
|
|
Re: Contest Tally
|
6
|
Resverlogix Corp.
|
Feb 21, 2019 10:54AM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
6
|
Resverlogix Corp.
|
May 12, 2017 10:57AM
|
|
Re: 2019 Annual and Special Meeting of Shareholders and Webcast of Corporate Update
|
6
|
Resverlogix Corp.
|
Oct 29, 2019 12:58PM
|
|
Re: That was one sweet day of trading....
|
6
|
Resverlogix Corp.
|
Aug 02, 2018 01:19PM
|
|
Re: We Need The Futility Analysis
|
6
|
Resverlogix Corp.
|
Feb 06, 2018 07:05PM
|
|
The beginning of the end game
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 06:23PM
|
|
Re: Great surge in PPS for fellow RVX investers
|
6
|
Zenith Epigenetics
|
Jun 20, 2018 12:29PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
6
|
Resverlogix Corp.
|
Jun 12, 2020 05:37PM
|
|
Re: Banging the Crestor drum ...
|
6
|
Resverlogix Corp.
|
Oct 02, 2019 09:13PM
|
|
Re: got this & sent a response/follow up minutes before …
|
6
|
Zenith Epigenetics
|
Dec 19, 2023 02:02PM
|
|
Re: So, why do the trial in Canada when the Americans have this program?
|
6
|
Resverlogix Corp.
|
Aug 06, 2021 05:42PM
|
|
Re: Gordon Research Conference
|
6
|
Resverlogix Corp.
|
May 30, 2019 05:02AM
|
|
Re: Accuracy
|
6
|
Resverlogix Corp.
|
Dec 21, 2016 12:04AM
|
|
Re: No mention of efficacy again...
|
6
|
Resverlogix Corp.
|
Mar 29, 2019 01:05PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
6
|
Resverlogix Corp.
|
Mar 14, 2022 02:49PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
6
|
Resverlogix Corp.
|
Sep 13, 2021 10:22PM
|
|
Re: Something "Material" is happening
|
6
|
Resverlogix Corp.
|
Mar 15, 2021 05:03PM
|
